Table 1.
Participants, n | 19 |
Female sex, n (%) | 11 (58) |
Age (years) | 43 (14) |
Caucasian, n (%) | 19 (100) |
Diabetes duration (years) | 20 (8–34) |
BMI (kg/m2) | 24.8 (22.0–25.7) |
Fasting plasma glucose (mmol/L) | 8.9 (2.3) |
HbA1c (%) | 7.4 (0.7) |
HbA1c (mmol/mol) | 57.1 (7.3) |
HOMA-IR | 0.9 (0.7–1.3) |
Complications, n | |
Retinopathy | 5 |
Microalbuminuria | 1 |
Transient ischemic attack | 1 |
Comorbidities, n | |
Hypertension | 3 |
Hypercholesterolemia | 9 |
Multiple sclerosis | 1 |
Treatment, n | |
Glimepiride | 18 |
Diet | 1 |
Data are mean (SD) or median (interquartile range) unless otherwise indicated. Diabetes duration is from manifest diabetes (first measurement of HbA1c ≥6.5% [≥48 mmol/mol]). HOMA-IR, HOMA of insulin resistance.